Compounds > exp3174
Page last updated: 2024-09-02

exp3174 and Hypertension, Renal

exp3174 has been researched along with Hypertension, Renal in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bunker, AM; Connolly, C; Edmunds, JJ; Hamby, JM; Hodges, JC; Kesten, SJ; Kostlan, CR; Quin, J; Sircar, I; Winters, RT1
Buczko, W; Kucharewicz, I; Matys, T; Pawlak, D; Pawlak, R1
Fujishima, K; Hachisu, M; Hui, C; Katano, K; Kawano, K; Konno, F; Nagura, J; Ogino, H; Yamamoto, M; Yasuda, S1
Basso, N; Cannata, MA; Kurnjek, ML; Ruiz, P1
Hashimoto, Y; Minami, K; Narita, H; Ohashi, R1

Other Studies

5 other study(ies) available for exp3174 and Hypertension, Renal

ArticleYear
Nonpeptide angiotensin II receptor antagonists. 2. Design, synthesis, and structure-activity relationships of 2-alkyl-4-(1H-pyrrol-1-yl)-1H-imidazole derivatives: profile of 2-propyl-1-[[2'-(1H-tetrazol-5-yl)-[1,1' -biphenyl]-4-yl]-methyl]-4-[2-(trifluoro
    Journal of medicinal chemistry, 1993, Aug-06, Volume: 36, Issue:16

    Topics: Angiotensin Receptor Antagonists; Animals; Aorta; Disease Models, Animal; GABA Antagonists; gamma-Aminobutyric Acid; Hypertension, Renal; Liver; Male; Muscle Contraction; Pyridines; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Structure-Activity Relationship

1993
Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7).
    Hypertension (Dallas, Tex. : 1979), 2002, Volume: 40, Issue:5

    Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Epoprostenol; Fibrinolytic Agents; Hypertension, Renal; Imidazoles; Infusions, Intravenous; Losartan; Male; Nitric Oxide; Nitric Oxide Synthase; Peptide Fragments; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles; Venous Thrombosis

2002
Pharmacological profile of ME3221, a novel angiotensin II receptor antagonist.
    European journal of pharmacology, 1995, Feb-14, Volume: 274, Issue:1-3

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta, Thoracic; Biphenyl Compounds; Blood Pressure; Bradykinin; Callithrix; Disease Models, Animal; Drug Evaluation; Female; Femoral Artery; Heart Rate; Hypertension, Renal; Imidazoles; Losartan; Male; Rabbits; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Species Specificity; Tetrazoles

1995
Effect of EXP 3174 on blood pressure of normoreninemic renal hypertensive rats.
    Hypertension (Dallas, Tex. : 1979), 1995, Volume: 25, Issue:2

    Topics: Angiotensinogen; Animals; Antihypertensive Agents; Arteries; Blood Pressure; Hypertension, Renal; Imidazoles; Injections, Intravenous; Injections, Intraventricular; Losartan; Male; Rats; Rats, Wistar; Renin; Tetrazoles

1995
Comparative study of TA-606, a novel angiotensin II receptor antagonist, with losartan in terms of species difference and orthostatic hypotension.
    Japanese journal of pharmacology, 1999, Volume: 81, Issue:1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Dogs; Dose-Response Relationship, Drug; Hypertension, Renal; Hypotension, Orthostatic; Imidazoles; Losartan; Male; Prodrugs; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Species Specificity; Tetrazoles

1999